Exenatide in Extreme Pediatric Obesity.

Trial Profile

Exenatide in Extreme Pediatric Obesity.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2012

At a glance

  • Drugs Exenatide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Sep 2012 Results presented at the 2012 Annual Meeting of the North American Association for the Study of Obesity.
    • 22 Sep 2012 Primary endpoint 'Body-mass-index' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top